Navigation Links
Myth of 'female impotence' created to boost sales,,

A recent article in the British Medical Journal has suggested that pharmaceutical companies have created a disease out of female sexual disorders and are defining the condition in order to unleash new markets for their products.

Drug companies are trying to recreate// the kind of market that Viagra, the drug used to treat male impotence, created during its launch in 1998.

Doctors however claim that female sexual disorders are being unduly medicalised and the coining of the term "female sexual dysfunction" makes an illness out of normal changes in women's sexual feelings which may happen after childbirth or being with the same partner for many years.

The article says that a group of researchers in close conjunction with pharma companies sponsoring meetings are defining a new category of illness to boost the sales of these companies. Doctors caution that the danger in creating such a myth is that it is likely to encourage doctors to prescribe drugs to change sexual function when attention should be paid to other aspects of a woman's life such as stress, tiredness or threatening behaviour from their partners.

However, a spokeswoman for one of the leading pharma companies denies such reports stating, "We work on unmet medical needs. There were academics who were working on this long before they came to us to ask us for support."


'"/>




Page: 1

Related medicine news :

1. Feeding channel created by malaria parasite - a new target for malaria treatments
2. Birth mark awareness created by internet helped to treat Cavernous hemangioma
3. Renewable Oocytes of Mice created hope in Human Fertility Treatment
4. Spirulina may be the next immune boost on the block
5. New drug helps boost cancer treatment
6. A boost to quit smoking
7. BCG vaccine to be boosted to effectively prevent tuberculosis
8. Trauma Research has to be boosted
9. Bio-engineered rice fortified with iron boost women health
10. Besides keeping you awake for exams coffee boosts memory as well!
11. Indias vaccination project gets a boost
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... ... February 12, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The ... uncovers what he says are the real facts surrounding all those Bible stories. For ... and Sunday school teachers, and Yisrayl says there is more to these than just ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Dignity Health ... General Hospital Emergency Room –Mesa. The new facility is licensed under Dignity ... , “Dr. Bingham is an excellent leader and will ensure our new freestanding emergency ...
(Date:2/11/2016)... ... 11, 2016 , ... SPH Analytics announced today that ... health solutions, MDinsight® and IndiGO®, for its primary care clinicians. The 3-year partnership ... the contract were not disclosed. , As the healthcare market moves towards quality-based ...
(Date:2/11/2016)... ... , ... Florida Hospital presents Heart Health Awareness night on Sunday February 14th, ... Amalie Arena. The puck drops at 6:00pm, but fans will have the opportunity to ... the game. The MEGA Heart will be located on Ford Thunder Alley and provide ...
(Date:2/11/2016)... Chicago, IL (PRWEB) , ... February 11, 2016 ... ... dedicated to the healthcare industry, ranked among the top five firms in the ... Services and HIT Implementation Support and Staffing. KLAS is a research and insights ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016  SI-BONE, Inc., a medical device company ... ("iFuse"), a minimally invasive surgical (MIS) device indicated for fusion for ... Services, Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... and SEOUL, South Korea ... Menarini and Macrogen, Inc. today announced they will ... innovative procedures for precision medicine in cancer. The ... Biosystems, DEPArray™ digital-sorting technology with Macrogen,s high-throughput Next ... certified under the Clinical Laboratory Improvement Amendments (CLIA) ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis ... completed a $47.1 million Series D preferred ... Asset Management, Hillhouse Capital Group and venBio ... Venture Investments, AJU IB Investment, and Epidarex ... used to further advance clinical trials in ...
Breaking Medicine Technology: